Transunion Form 4 insider transactions

NYSE
Pamela A. Joseph, a director of TransUnion, reported the acquisition of 2,463 shares of restricted stock on May 7, 2025, vesting on the first anniversary of the grant date.
NYSE
Steven M. Chaouki, President of US Markets at TransUnion, sold 1,000 shares of common stock at $82.96 per share on May 1, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Mohamed Abdelsadek, EVP, Chief Global Solutions at TransUnion, reports the acquisition of restricted stock units on April 1, 2025.
NYSE
Steven M. Chaouki, President of US Markets at TransUnion, sold 1,000 shares of common stock at $83.31 per share on April 1, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
EVP of Global Solutions at TransUnion, Timothy J. Martin, sold 2,500 shares of common stock on March 6, 2025, at a price of $88.64 per share.
NYSE
Jennifer A. Williams, SVP, Chief Accounting Officer at TransUnion, reports acquisition and disposal of common stock and grant of restricted stock units.
NYSE
EVP and Chief Operations Officer of TransUnion, Tiffani Chambers, reports the acquisition of restricted stock units.
NYSE
EVP and Chief Legal Officer of TransUnion, Heather J. Russell, reports acquisition of restricted stock units and disposal of common stock.
NYSE
Todd C. Skinner, President, International at TransUnion, reports acquiring restricted stock units and disposing of common stock on February 28, 2025.
NYSE
EVP of Global Solutions at TransUnion, Timothy J. Martin, reports the acquisition of 5,409 restricted stock units.
NYSE
Steven M. Chaouki, President of US Markets at TransUnion, reports acquisition of restricted stock units and sale of common stock.
NYSE
EVP, Chief Tech, Data & Analy. Venkat Achanta reports acquisition and disposal of TransUnion (TRU) common stock, including vesting of restricted stock units and sales under a 10b5-1 trading plan.
NYSE
Todd M. Cello, EVP & CFO of TransUnion, reports the acquisition of 16,228 restricted stock units.
NYSE
TransUnion's CEO, Christopher Cartwright, reported the acquisition of restricted stock units and disposal of common stock in a recent SEC filing.
NYSE
Jennifer A. Williams, SVP, Chief Accounting Officer of TransUnion, sold 200 shares of common stock at a price of $95.74 on February 26, 2025, under a Rule 10b5-1 trading plan.
NYSE
EVP, Chief Tech, Data & Analytics Officer of TransUnion, Venkat Achanta, sold 1,821 shares of common stock at $95.74 per share under a pre-arranged 10b5-1 trading plan.
NYSE
Jennifer A. Williams, SVP and Chief Accounting Officer of TransUnion, reports the acquisition of 307 shares and disposal of 107 shares of common stock related to vesting of performance share units.
NYSE
Todd C. Skinner, President, International at TransUnion, reports acquisition of 1,986 shares and disposal of 1,073 shares of common stock on February 25, 2025.
NYSE
Heather J. Russell, EVP and Chief Legal Officer of TransUnion, reports acquisition of 1,986 shares and disposal of 923 shares of common stock on February 25, 2025.
NYSE
EVP, CHRO of TransUnion, Susan W. Muigai, reports acquisition of 1,655 shares and disposal of 782 shares of common stock on February 25, 2025.
NYSE
EVP Timothy J. Martin of TransUnion reports acquisition of shares through vesting of performance share units and subsequent disposal to cover tax obligations.
NYSE
Steven M. Chaouki, President of US Markets at TransUnion, reports acquisition and disposal of common stock related to vesting of performance share units.
NYSE
EVP, Chief Tech, Data & Analytics of TransUnion, Achanta Venkat, reports acquisition of 3,063 shares and disposal of 1,242 shares of common stock on February 25, 2025.
NYSE
Todd M. Cello, EVP & CFO of TransUnion, reports acquisition of 3,891 shares and disposal of 1,763 shares of common stock on February 25, 2025.
NYSE
Christopher Cartwright, President and CEO of TransUnion, reports acquisition of shares through vesting of performance share units and subsequent disposal to cover tax obligations.
NYSE
Steven M. Chaouki, President of US Markets at TransUnion, sold 1,000 shares of common stock on February 3, 2025, at a price of $95.95 per share, according to a Form 4 filing with the SEC.
NYSE
TransUnion's President of US Markets, Steven M. Chaouki, sold 1,000 shares of common stock at $93.6 per share on January 2, 2025, under a pre-arranged 10b5-1 trading plan.
NYSE
TransUnion's EVP, CHRO, Susan W. Muigai, was granted 505 restricted stock units on December 2, 2024, which will vest over three years.
NYSE
TransUnion's President of US Markets, Steven M. Chaouki, sold 1,500 shares of common stock at $100.73 per share on December 2, 2024, under a pre-arranged 10b5-1 trading plan.
NYSE
Todd C. Skinner, President of International at TransUnion, sold 3,090 shares of common stock at an average price of $101.48 on November 29, 2024.